• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation.

作者信息

Phan Kevin, Wang Nelson, Pison Laurent, Kumar Narendra, Hitos Kerry, Thomas Stuart P

机构信息

Department of Cardiology, Westmead Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.

University of Sydney, Sydney, Australia.

出版信息

Int J Cardiol. 2015 Jun 15;189:199-203. doi: 10.1016/j.ijcard.2015.04.072. Epub 2015 Apr 11.

DOI:10.1016/j.ijcard.2015.04.072
PMID:25897906
Abstract
摘要

相似文献

1
Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation.达比加群与华法林用于心房颤动导管消融患者的荟萃分析。
Int J Cardiol. 2015 Jun 15;189:199-203. doi: 10.1016/j.ijcard.2015.04.072. Epub 2015 Apr 11.
2
Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.中断达比加群用于房颤导管消融术围手术期抗凝的安全性和有效性：系统评价和荟萃分析。
Europace. 2013 Oct;15(10):1412-20. doi: 10.1093/europace/eut239. Epub 2013 Aug 16.
3
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.非桥接的达比加群酯与华法林用于房颤消融
N Engl J Med. 2017 Apr 27;376(17):1627-1636. doi: 10.1056/NEJMoa1701005. Epub 2017 Mar 19.
4
Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.竞争性口服抗凝剂在心房颤动射频导管消融患者中疗效和安全性的网状荟萃分析。
J Interv Card Electrophysiol. 2016 Sep;46(3):213-24. doi: 10.1007/s10840-016-0126-5. Epub 2016 Mar 21.
5
[The Use of Dabigatran for Prevention of Thromboembolic Complications in Patients Underwent Atrial Fibrillation Catheter Ablation].达比加群用于预防心房颤动导管消融术后患者血栓栓塞并发症的应用
Kardiologiia. 2015;55(4):30-5. doi: 10.18565/cardio.2015.4.30-35.
6
Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.新型口服抗凝剂与不间断使用华法林相比用于房颤导管消融术的安全性。
Ann Pharmacother. 2015 Mar;49(3):278-84. doi: 10.1177/1060028014563950. Epub 2014 Dec 16.
7
Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.非瓣膜性心房颤动导管消融中直接口服抗凝剂与维生素 K 拮抗剂不间断治疗的比较：随机对照试验的系统评价和荟萃分析。
Europace. 2018 Oct 1;20(10):1612-1620. doi: 10.1093/europace/euy133.
8
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.在接受导管消融治疗心房颤动的患者中，达比加群用于围手术期抗凝。
Circ Arrhythm Electrophysiol. 2013 Jun;6(3):460-6. doi: 10.1161/CIRCEP.113.000320. Epub 2013 Apr 3.
9
Does dabigatran interfere with intraablation heparinization?
Thromb Res. 2014 Sep;134(3):742-3. doi: 10.1016/j.thromres.2014.06.026. Epub 2014 Jul 5.
10
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study.达比加群与华法林在心房颤动导管消融术中持续抗凝期间患者特征及结局的区域差异：RE-CIRCUIT研究
J Interv Card Electrophysiol. 2019 Aug;55(2):145-152. doi: 10.1007/s10840-019-00518-x. Epub 2019 Feb 13.

引用本文的文献

1
UBLED AF (Uninterrupted BLackpool EDoxaban vs Warfarin vs Rivaroxaban in Atrial Fibrillation/Flutter ablation) Study.UBLED AF（房颤/房扑消融术中不间断使用拜瑞妥与华法林及利伐沙班对比）研究
J Atr Fibrillation. 2021 Aug 31;14(2):20200445. doi: 10.4022/jafib.20200445. eCollection 2021 Aug.
2
Left atrial appendage thrombus formation in a patient with atrial fibrillation on dabigatran therapy associated with CES1 and ABCB1 genetic polymorphisms: A case report.达比加群治疗的房颤患者左心耳血栓形成与CES1和ABCB1基因多态性相关：一例报告
Medicine (Baltimore). 2020 Sep 4;99(36):e22084. doi: 10.1097/MD.0000000000022084.
3
Left Atrium and Left Atrial Appendage Screening Prior to Atrial Fibrillation Ablation: A Comprehensive Review of the Literature.
心房颤动消融术前左心房及左心耳筛查：文献综述
J Innov Card Rhythm Manag. 2018 May 15;9(5):3163-3171. doi: 10.19102/icrm.2018.090502. eCollection 2018 May.
4
Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures.心脏复律和侵入性电生理手术前后直接口服抗凝剂的围手术期管理。
Cardiol Rev. 2018 Sep/Oct;26(5):245-254. doi: 10.1097/CRD.0000000000000188.
5
Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score.在导管消融治疗中，低CHADS2评分的房颤患者使用达比加群与华法林联合低分子量肝素桥接治疗的比较。
Biomed Rep. 2017 May;6(5):549-554. doi: 10.3892/br.2017.880. Epub 2017 Mar 28.
6
Atrial fibrillation: review of current treatment strategies.心房颤动：当前治疗策略综述
J Thorac Dis. 2016 Sep;8(9):E886-E900. doi: 10.21037/jtd.2016.09.13.
7
Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.某些抗凝剂是否比其他的更具优势？——评估新型口服抗凝剂在房颤消融中的作用
Curr Cardiol Rev. 2016;12(4):330-335. doi: 10.2174/1573403x12666160505113755.